Characterisation of nimesulide-betacyclodextrins systems prepared by supercritical fluid impregnation

被引:19
作者
Moneghini, A
Kikic, I
Perissutti, B
Franceschinis, E
Cortesi, A
机构
[1] Univ Trieste, Dept Pharmaceut Sci, I-34127 Trieste, Italy
[2] Dept Chem Environm & Raw Mat Engn, Trieste, Italy
关键词
supercritical CO2 impregnation; nimesulide; betacyclodextrins; physico-chemical characterisation; dissolution enhancement;
D O I
10.1016/j.ejpb.2004.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to apply the supercritical CO2 impregnation process for preparing solvent-free nimesulide (NMS)-betacyclodextrins (BCD) association systems with enhanced drug dissolution rate. Several drug-to-carrier molar ratios were tested (1:1; 1:2.5; 1:3.5) at different conditions of temperatures (40, 100, and 130degreesC) and pressures (140, 190 or 220 bar). The physical and morphological characterisation of the systems using powder X-ray diffraction, thermal analysis, diffuse reflectance Fourier transform-infrared spectroscopy and scanning electron microscopy was carried out to understand the influence of this technological process on the physical status of single components and binary systems and to detect possible interactions between drug and carrier. These analyses provided no evidence of a complete inclusion of NMS in the carrier but the existence of interactions between drug and carrier together with a partial dehydration of the BCD and the formation of drug crystallites with lower melting point and heat of fusion than the native NMS. These phenomena were more intense when severe conditions of pressure and temperature (220 bar and 130 degreesC were used during impregnation trials and when the amount of BCD augmented in the systems. These activated solid state of the impregnated systems promoted an enhancement of drug dissolution rate that, in keeping with the results of the physical characterisation, was function of the process conditions and BCD content. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 19 条
[1]   Microstructural investigation of nimesulide-crospovidone composites by X-ray diffraction and thermal analysis [J].
Bergese, P ;
Bontempi, E ;
Colombo, I ;
Gervasoni, D ;
Depero, LE .
COMPOSITES SCIENCE AND TECHNOLOGY, 2003, 63 (08) :1197-1201
[2]   Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin [J].
Charoenchaitrakool, M ;
Dehghani, F ;
Foster, NR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :103-112
[3]   Nimesulide and β-cyclodextrin inclusion complexes:: Physicochemical characterization and dissolution rate studies [J].
Chowdary, KPR ;
Nalluri, BN .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (11) :1217-1220
[4]   Fractal analysis of β-cyclodextrin-indomethacin particles compacted by ultrasound [J].
Fini, A ;
Fernàndez-Hervàs, MJ ;
Holgado, MA ;
Rodriguez, L ;
Cavallari, C ;
Passerini, N ;
Caputo, O .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (11) :1303-1309
[5]   Thermal analysis of cyclodextrins and their inclusion compounds [J].
Giordano, F ;
Novak, C ;
Moyano, JR .
THERMOCHIMICA ACTA, 2001, 380 (02) :123-151
[6]   A comparative study of naproxen - Beta cyclodextrin complexes prepared by conventional methods and using Supercritical carbon dioxide [J].
Junco, S ;
Casimiro, T ;
Ribeiro, N ;
Da Ponte, MN ;
Marques, HC .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2002, 44 (1-4) :117-121
[7]   Solubility of anti-inflammatory drugs in supercritical carbon dioxide [J].
Macnaughton, SJ ;
Kikic, I ;
Foster, NR ;
Alessi, P ;
Cortesi, A ;
Colombo, I .
JOURNAL OF CHEMICAL AND ENGINEERING DATA, 1996, 41 (05) :1083-1086
[8]  
Magarotto L., 2001, J. Metastable Nanocryst. Mater, V10, P643
[9]   USE OF DEHYDRATED BETA-CYCLODEXTRIN AS PHARMACEUTICAL EXCIPIENT [J].
MARTINI, A ;
TORRICELLI, C ;
MUGGETTI, L ;
DEPONTI, R .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (15) :2381-2393
[10]   Inclusion complexes of tretinoin with cyclodextrins [J].
Montassier, P ;
Duchene, D ;
Poelman, MC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 153 (02) :199-209